Alaunos Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Alaunos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • Alaunos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.6M shares, a 99.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.6M -239M -99.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 16M -225M -93.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.6M -14.4M -90% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 241M +24.4M +11.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 241M +24.5M +11.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 241M +24.7M +11.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 16M -200M -92.6% Dec 31, 2022 10-K 2024-04-01
Q3 2022 216M +36.2K +0.02% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 216M +615K +0.29% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 216M +693K +0.32% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 216M +1.54M +0.72% Dec 31, 2021 10-K 2023-03-07
Q3 2021 216M +1.98M +0.93% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 216M +1.27M +0.59% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 215M +971K +0.45% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 215M +32.8M +18% Dec 31, 2020 10-K 2022-03-30
Q3 2020 214M +33.1M +18.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 214M +51.8M +31.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 214M +52M +32% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 182M +20.7M +12.9% Dec 31, 2019 10-K 2021-03-01
Q3 2019 181M +38.7M +27.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 162M +20.1M +14.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 162M +19.9M +14% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 161M +18.4M +12.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 142M +417K +0.29% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 142M +417K +0.29% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 142M +10M +7.57% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 143M +10.3M +7.77% Dec 31, 2017 10-K 2019-03-05
Q3 2017 142M +10.2M +7.77% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 142M +10.2M +7.77% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 132M +579K +0.44% Mar 31, 2017 10-Q 2017-05-01
Q4 2016 132M +658K +0.5% Dec 31, 2016 10-K 2018-03-01
Q3 2016 132M +845K +0.65% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 132M +910K +0.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 132M +3.57M +2.78% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 132M +27.3M +26.1% Dec 31, 2015 10-K 2017-02-16
Q3 2015 131M +28.2M +27.5% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 131M +30.1M +29.9% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 128M +27.6M +27.5% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 104M +4.29M +4.29% Dec 31, 2014 10-K 2016-02-24
Q3 2014 103M +19M +22.7% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 101M +17.2M +20.6% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 101M +16.9M +20.2% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 100M +16.9M +20.3% Dec 31, 2013 10-K 2015-02-26
Q3 2013 83.7M +4.06M +5.1% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 83.5M +3.92M +4.92% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 83.7M +4.15M +5.22% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 83.2M +14M +20.3% Dec 31, 2012 10-K 2014-03-03
Q3 2012 79.6M +11.2M +16.3% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 79.6M +11.3M +16.6% Jun 30, 2012 10-Q/A 2012-08-28
Q1 2012 79.5M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 69.2M +20.7M +42.8% Dec 31, 2011 10-K 2013-03-18
Q3 2011 68.5M +19.9M +41% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 68.3M Jun 30, 2011 10-Q/A 2011-08-09
Q4 2010 48.5M Dec 31, 2010 10-K 2012-02-29
Q3 2010 48.6M Sep 30, 2010 10-Q 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.